Bioline Rx (BLRX) EPS (2010 - 2026)
Bioline Rx (BLRX) EPS from Jun 30, 2010 to Mar 31, 2026. The TTM Bioline Rx (BLRX) EPS is -$2.15. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Bioline Rx (BLRX) EPS CAGR table
| Period | CAGR |
|---|---|
| 5 Years TTM | +8.84% |
| 10 Years TTM | -5.58% |
Annual EPS change of Bioline Rx (BLRX)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.58 | +102.62% |
| 2025 | -$0.29 | -83.87% |
| 2020 | -$1.78 | -31.70% |
| 2019 | -$2.61 | -17.78% |
| 2018 | -$3.17 | -21.88% |
| 2017 | -$4.06 | -4.07% |
| 2016 | -$4.23 | +0.72% |
| 2015 | -$4.20 | -10.66% |
| 2014 | -$4.70 | -60.03% |
| 2013 | -$11.77 | -34.93% |
| 2012 | -$18.08 | -290.24% |
| 2010 | $9.50 | N/A |
Comparison Bioline Rx (BLRX) five years EPS CAGR with competitors
Bioline Rx (BLRX) five years EPS CAGR is -12.74%.